Fibroid
21
3
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.8%
1 terminated out of 21 trials
87.5%
+1.0% vs benchmark
38%
8 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (21)
Prescription of Letrozole for Uterine Myoma
The Sequestration of Holistic Stress Management Techniques for Adults
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Fibroids and the Risk of Miscarriage: a Prospective Observational Study in an Early Pregnancy Population
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
Evaluation of Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease
Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women
Ulipristal Use in Chinese Population
Laparoscopic Myomectomy Using Barbed or Conventional Sutures
Oxytocin in MRI-HIFU
Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis
Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy
Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential